Genesem Inc. (KOSDAQ:217190)
South Korea · Delayed Price · Currency is KRW 5,900.00
-300.00 (-4.84%)
At close: May 29, 2026
Genesem Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 55,055 | 56,757 | 68,738 | 56,454 | 59,603 | 59,727 |
Other Revenue | - | - | -0 | - | - | - |
| 55,055 | 56,757 | 68,738 | 56,454 | 59,603 | 59,727 | |
Revenue Growth (YoY) | -15.55% | -17.43% | 21.76% | -5.28% | -0.21% | 42.41% |
Cost of Revenue | 35,303 | 36,027 | 39,752 | 36,627 | 35,601 | 39,109 |
Gross Profit | 19,752 | 20,730 | 28,986 | 19,827 | 24,002 | 20,619 |
Selling, General & Admin | 14,242 | 12,885 | 14,790 | 10,573 | 10,160 | 10,280 |
Research & Development | 5,351 | 5,532 | 5,693 | 4,385 | 4,161 | 3,583 |
Amortization of Goodwill & Intangibles | 124.45 | 119.61 | 125.69 | 109.25 | 95.02 | 116.68 |
Other Operating Expenses | 307.6 | 299.76 | 266.44 | 272.35 | 259.36 | 287.43 |
Operating Expenses | 19,879 | 19,701 | 22,445 | 16,265 | 15,484 | 14,985 |
Operating Income | -126.68 | 1,029 | 6,541 | 3,562 | 8,519 | 5,633 |
Interest Expense | -625.48 | -675.91 | -879.04 | -876.24 | -665.08 | -540.98 |
Interest & Investment Income | 338.57 | 345.03 | 401.21 | 320.22 | 157.35 | 18.89 |
Earnings From Equity Investments | -238.14 | -87.32 | - | - | - | - |
Currency Exchange Gain (Loss) | 351.74 | -392.98 | 1,119 | 85.02 | 473.2 | 349.11 |
Other Non Operating Income (Expenses) | 80.95 | 55.86 | 3.85 | -7.44 | -103.38 | -139.39 |
EBT Excluding Unusual Items | -219.04 | 273.94 | 7,187 | 3,083 | 8,381 | 5,321 |
Gain (Loss) on Sale of Investments | 19.7 | -4.91 | 23.1 | 30.38 | 17.23 | 11.55 |
Gain (Loss) on Sale of Assets | 26.22 | 24.72 | -17.85 | - | - | 0.77 |
Asset Writedown | - | - | - | - | -15 | - |
Pretax Income | -173.12 | 293.75 | 7,192 | 3,114 | 8,383 | 5,333 |
Income Tax Expense | -698.34 | -653.51 | 1,071 | -482.29 | -3,807 | 90.66 |
Earnings From Continuing Operations | 525.22 | 947.26 | 6,121 | 3,596 | 12,190 | 5,242 |
Minority Interest in Earnings | -39.15 | -12.23 | -36.91 | 129.32 | 43.22 | 0.13 |
Net Income | 486.07 | 935.03 | 6,084 | 3,725 | 12,233 | 5,243 |
Net Income to Common | 486.07 | 935.03 | 6,084 | 3,725 | 12,233 | 5,243 |
Net Income Growth | -88.63% | -84.63% | 63.31% | -69.55% | 133.34% | - |
Shares Outstanding (Basic) | 13 | 13 | 13 | 13 | 13 | 13 |
Shares Outstanding (Diluted) | 13 | 13 | 13 | 13 | 13 | 13 |
EPS (Basic) | 36.95 | 71.08 | 462.53 | 283.22 | 930.00 | 398.56 |
EPS (Diluted) | 36.95 | 71.08 | 462.53 | 283.22 | 930.00 | 398.56 |
EPS Growth | -88.61% | -84.63% | 63.31% | -69.55% | 133.34% | - |
Free Cash Flow | -7,212 | -4,348 | 8,578 | 2,759 | 8,250 | 3,577 |
Free Cash Flow Per Share | -548.32 | -330.57 | 652.15 | 209.77 | 627.16 | 271.90 |
Gross Margin | 35.88% | 36.52% | 42.17% | 35.12% | 40.27% | 34.52% |
Operating Margin | -0.23% | 1.81% | 9.52% | 6.31% | 14.29% | 9.43% |
Profit Margin | 0.88% | 1.65% | 8.85% | 6.60% | 20.52% | 8.78% |
Free Cash Flow Margin | -13.10% | -7.66% | 12.48% | 4.89% | 13.84% | 5.99% |
EBITDA | 1,077 | 2,222 | 7,835 | 4,779 | 9,715 | 6,828 |
EBITDA Margin | 1.96% | 3.91% | 11.40% | 8.46% | 16.30% | 11.43% |
D&A For EBITDA | 1,204 | 1,193 | 1,293 | 1,217 | 1,196 | 1,195 |
EBIT | -126.68 | 1,029 | 6,541 | 3,562 | 8,519 | 5,633 |
EBIT Margin | -0.23% | 1.81% | 9.52% | 6.31% | 14.29% | 9.43% |
Effective Tax Rate | - | - | 14.89% | - | - | 1.70% |
Advertising Expenses | - | 162.42 | 206.01 | 68.25 | 64.28 | 14.84 |